Skip Nav Destination
Issues
1 October 2017
-
Cover Image
Cover Image
ABOUT THE COVER
Most vertebrate cells contain immotile microtubule-based organelles known as primary cilia. Previous study has suggested the importance of Hedgehog signaling to ciliogenesis, and that inhibition of this process promotes more aggressive disease phenotypes. Here, genetically engineered mouse models were used to define the role of Hedgehog signaling in the context of inhibition of ciliogenesis. The cover displays immunofluorescent images of mammary tissue from the Ift88fl/fl/PyMT+ transgenic mouse model. Ift88 is required for intraflagellar transport and loss has been shown to inhibit ciliogenesis. The left image is immunostained for a myoepithelial marker (CK5, white) and nuclei (Hoechst, blue), the upper middle image is immunostained for the cilia marker (ARL13b red) and centrosome marker (γ-tubulin, green), and the lower image is a merged image. The larger center image is an artistic rendering of the merged image. Please see the article by Hassounah and colleagues (beginning on page 1421) for more details. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1541-7786
EISSN 1557-3125
Molecular Cancer Research
Table of Contents
Highlights
Rapid Impact
Cell Death and Survival
Author Choice
Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells
Ahmed A. Mohamed; Shyh-Han Tan; Charles P. Xavier; Shilpa Katta; Wei Huang; Lakshmi Ravindranath; Muhammad Jamal; Hua Li; Meera Srivastava; Eri S. Srivatsan; Taduru L. Sreenath; David G. McLeod; Alagarsamy Srinivasan; Gyorgy Petrovics; Albert Dobi; Shiv Srivastava
Tuberin Regulates Prostaglandin Receptor–Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells
Chenggang Li; Xiaolei Liu; Yang Liu; Erik Zhang; Kantha Medepalli; Kouhei Masuda; Na Li; Kathryn A. Wikenheiser-Brokamp; Andrew Osterburg; Michael T. Borchers; Elizabeth J. Kopras; David R. Plas; Julia Sun; David N. Franz; Jamie K. Capal; Maxwell Mays; Yang Sun; David J. Kwiatkowski; Anya Alayev; Marina K. Holz; Darcy A. Krueger; Brian J. Siroky; Jane J. Yu
Chromatin, Epigenetics, and RNA Regulation
Genomics
Author Choice
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC
Masafumi Horie; Bogumil Kaczkowski; Mitsuhiro Ohshima; Hirotaka Matsuzaki; Satoshi Noguchi; Yu Mikami; Marina Lizio; Masayoshi Itoh; Hideya Kawaji; Timo Lassmann; Piero Carninci; Yoshihide Hayashizaki; Alistair R.R. Forrest; Daiya Takai; Yoko Yamaguchi; Patrick Micke; Akira Saito; Takahide Nagase
Metabolism
Oncogenes and Tumor Suppressors
Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation
Zahra Hassani; Ali Saleh; Soumaya Turpault; Salim Khiati; Willy Morelle; Jacques Vignon; Jean-Philippe Hugnot; Emmanuelle Uro-Coste; Philippe Legrand; Marcel Delaforge; Séverine Loiseau; Ludovic Clarion; Marc Lecouvey; Jean-Noël Volle; David Virieux; Jean-Luc Pirat; Hugues Duffau; Norbert Bakalara
Signal Transduction
BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity
Caroline M. Emery; Kelli-Ann Monaco; Ping Wang; Marissa Balak; Alyson Freeman; Jodi Meltzer; Scott M. Delach; Daniel Rakiec; David A. Ruddy; Joshua M. Korn; Jacob Haling; Michael G. Acker; Giordano Caponigro
EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer
Yasuyuki Okada; Tetsuo Kimura; Tadahiko Nakagawa; Koichi Okamoto; Akira Fukuya; Takahiro Goji; Shota Fujimoto; Masahiro Sogabe; Hiroshi Miyamoto; Naoki Muguruma; Yasushi Tsuji; Toshiya Okahisa; Tetsuji Takayama
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.